Tolinapant
- Generic Name
- Tolinapant
- Drug Type
- Small Molecule
- Chemical Formula
- C30H42FN5O3
- CAS Number
- 1799328-86-1
- Unique Ingredient Identifier
- 2LHZ9ZC3YO
- Background
ASTX660 is under investigation in clinical trial NCT02503423 (Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas).
Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2025-01-07
- Lead Sponsor
- Taiho Oncology, Inc.
- Target Recruit Count
- 230
- Registration Number
- NCT02503423
- Locations
- 🇺🇸
West Penn Hospital, Pittsburgh, Pennsylvania, United States
🇺🇸MD Anderson Cancer Center, Houston, Texas, United States
🇺🇸University of Washington, Seattle Cancer Care Alliance, Seattle, Washington, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath